登录 | 注册    关注公众号  
微信公众号
搜索
 > 【MOG】

MOG信息

英文名称:Myelin-oligodendrocyte glycoprotein
中文名称:髓鞘少突胶质细胞糖蛋白
靶点别称:NRCLP7,Myelin-oligodendrocyte glycoprotein,MOG,Myelin Oligodendrocyte Glycoprotein,MOG Ig-AluB,MOG Alpha-5,MOG AluA,MOG AluB,BTNL11,MOGIG2,BTN6
上市药物数量:0
临床药物数量:1
最高研发阶段:临床二期

MOG分子别名

MOG,BTN6,BTNL11,MOGIG2,NRCLP7,Myelin oligodendrocyte glycoprotein

MOG分子背景

Myelin oligodendrocyte glycoprotein (MOG), is a single-pass transmembrane glycoprotein of the immunoglobulin (Ig) superfamily. MOG is a myelin protein exclusively expressed in the CNS at the outermost surface of myelin sheaths and oligodendrocyte membranes. This makes MOG a potential target of cellular and humoral immune responses in inflammatory demyelinating diseases. Due to its late postnatal developmental expression, MOG is an important marker for oligodendrocyte maturation.

MOG临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
MOG autologous T-lymphocyte cell therapy (ImCyse) 临床二期 Imcyse Sa 多发性硬化 详情

消息提示

请输入您的联系方式,再点击提交!

确定